Monitor next quarterly earnings for any strategic shift under new CEO; watch for any restructuring or divestiture announcements as new leadership often signals a new direction
Price Chart
Executive Summary
AngioDynamics appointed Eric Honroth as President and CEO effective November 2, 2026, succeeding retiring CEO Jim Clemmer, who will remain as a consultant for one year. The company also entered into retention agreements with the executive leadership team and disclosed the retirement of Chairman Howard Donnelly at the end of his term. This is a routine CEO succession with structured transition support.
Key Facts
- Eric Honroth appointed President and CEO, effective November 2, 2026; base salary $735,000/year; target annual bonus 95% of base salary; initial inducement award $1,487,116 (350% of base salary prorated); equity buy-out award $450,000; cash sign-on bonus $10,000; commuting allowance $10,000/month for 24 months; auto allowance $24,000/year
- Jim Clemmer retires as CEO; enters consulting agreement for one year at $30,000/month; lump-sum payment if terminated early
- Retention agreements with executive leadership team: equity acceleration of restricted share units and pro-rata performance share units for non-resignation, non-cause termination within 12 months of new CEO start
- Howard Donnelly to retire as Class II director at end of current term
- No financial results, guidance, or material operational data in this filing
Financial Impact
CEO compensation package up to ~$2.3M in initial grants plus ongoing salary and bonus; consulting fee $360,000 over one year; retention agreements have no immediate cash cost; no impact on revenue or earnings
Risk Factors
- New CEO has no prior experience at AngioDynamics; execution risk on transformation may not meet expectations
- Retention agreements may signal potential future equity dilution if retention benefits are triggered
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-039019 |
| Document: ef20083270_8k.htm | 0001140361-26-039019 |
| Document: ef20083270_ex10-2.htm | 0001140361-26-039019 |
| Document: ef20083270_ex99-1.htm | 0001140361-26-039019 |
| Document: ef20083270_ex10-3.htm | 0001140361-26-039019 |
| Document: 0001140361-26-039019-index-headers.html | 0001140361-26-039019 |
| Document: 0001140361-26-039019-index.html | 0001140361-26-039019 |
| Document: 0001140361-26-039019.txt | 0001140361-26-039019 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 19d ago | DEFA14A | $11.23 $11.58 | ▲ +3.12% | ▲ +3.39% | $12.26 (+9.17%) |
Oct 8, 2026 19d ago | DEF 14A | $11.23 $11.58 | ▲ +3.12% | ▲ +3.39% | $12.26 (+9.17%) |
Oct 8, 2026 19d ago | 8-K | $11.23 $11.58 | ▲ +3.12% | ▲ +3.39% | $12.26 (+9.17%) |
Oct 8, 2026 19d ago | 8-K | $11.23 $11.58 | ▲ +3.12% | ▲ +3.39% | $12.26 (+9.17%) |
Jul 14, 2026 15w ago | 8-K | $13.00 $13.71 | ▲ +5.46% | ▲ +6.76% | $12.26 (−5.69%) |
Apr 2, 2026 29w ago | 8-K | $10.31 $9.80 | ▼ −4.95% | ▼ −8.57% | $12.26 (+18.91%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers